20-F Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 FY 2017

Filing Information

Form Type	20-F
Accession Number	`0001213900-18-003218`
Period End Date	20171231
Filing Date	20180320
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	clgn-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 55 Cash Flow Statement 116 Stockholders Equity 37

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	11.06M	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$1.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Trade receivables	`TradeReceivables`	$102.00K	USD	Point-in-time
Trade receivables	`TradeReceivables`	217,000.00	ILS	Point-in-time
Trade receivables	`TradeReceivables`	354,000.00	ILS	Point-in-time
Other	`OtherCurrentReceivables`	3.57M	ILS	Point-in-time
Other	`OtherCurrentReceivables`	$1.02M	USD	Point-in-time
Other	`OtherCurrentReceivables`	3.54M	ILS	Point-in-time
Inventory	`Inventories`	$202.00K	USD	Point-in-time
Inventory	`Inventories`	700,000.00	ILS	Point-in-time
Inventory	`Inventories`	487,000.00	ILS	Point-in-time
Total current assets	`CurrentAssets`	8.07M	ILS	Point-in-time
Total current assets	`CurrentAssets`	22.41M	ILS	Point-in-time
Total current assets	`CurrentAssets`	$6.46M	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	557,000.00	ILS	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$145.00K	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	503,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	92,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	168,000.00	ILS	Point-in-time
Long term-receivables	`NoncurrentAssetsLongTermReceivables`	$27.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$1.03M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	4.01M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	3.58M	ILS	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	2.61M	ILS	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.45M	ILS	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	$419.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsAndGoodwill`	1.63M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	5.63M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	6.36M	ILS	Point-in-time
Total non-current assets	`NoncurrentAssets`	$1.62M	USD	Point-in-time
Total assets	`Assets`	14.43M	ILS	Point-in-time
Total assets	`Assets`	$8.09M	USD	Point-in-time
Total assets	`Assets`	28.05M	ILS	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	2.92M	ILS	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$843.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	5.19M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	1.62M	ILS	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$576.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	2.00M	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	4.92M	ILS	Point-in-time
Total current liabilities	`CurrentLiabilities`	$1.42M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	6.81M	ILS	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	12.64M	ILS	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	$3.65M	USD	Point-in-time
Debentures at fair value	`NoncurrentFinancialLiabilities`	-	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	-	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	141,000.00	ILS	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$41.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	$345.00K	USD	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	1.20M	ILS	Point-in-time
Royalties to the Israel Innovation Authority	`RoyaltiesToIsraelInnovationAuthority`	2.18M	ILS	Point-in-time
Long-term payables	`LongTermPayables`	$18.00K	USD	Point-in-time
Long-term payables	`LongTermPayables`	286,000.00	ILS	Point-in-time
Long-term payables	`LongTermPayables`	61,000.00	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	14.04M	ILS	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$4.05M	USD	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	2.47M	ILS	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	ILS	Point-in-time
Commitments and contingent liabilities	`CommitmentsAndContingentLiabilities`	-	ILS	Point-in-time
Total liabilities	`Liabilities`	9.27M	ILS	Point-in-time
Total liabilities	`Liabilities`	$5.47M	USD	Point-in-time
Total liabilities	`Liabilities`	18.96M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	3.21M	ILS	Point-in-time
Ordinary shares	`OrdinaryShares`	$1.44M	USD	Point-in-time
Ordinary shares	`OrdinaryShares`	5.00M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$51.48M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	159.86M	ILS	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	178.47M	ILS	Point-in-time
Accumulated deficit	`RetainedEarnings`	-174.38M	ILS	Point-in-time
Accumulated deficit	`RetainedEarnings`	-157.91M	ILS	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-50.30M	USD	Point-in-time
Total equity	`Equity`	5.16M	ILS	Point-in-time
Total equity	`Equity`	9.08M	ILS	Point-in-time
Total equity	`Equity`	14.31M	ILS	Point-in-time
Total equity	`Equity`	9.78M	ILS	Point-in-time
Total equity	`Equity`	$2.62M	USD	Point-in-time
Total equity	`Equity`	$1.49M	USD	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	$8.09M	USD	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	14.43M	ILS	Point-in-time
Total liabilities and equity	`EquityAndLiabilities`	28.05M	ILS	Point-in-time

Income Statement 55 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenue`	1.67M	ILS	Annual
Revenue	`Revenue`	$481.00K	USD	Annual
Revenue	`Revenue`	292,000.00	ILS	Annual
Revenue	`Revenue`	-	ILS	Annual
Cost of Revenue	`CostOfSales`	52,000.00	ILS	Annual
Cost of Revenue	`CostOfSales`	-	ILS	Annual
Cost of Revenue	`CostOfSales`	$15.00K	USD	Annual
Cost of Revenue	`CostOfSales`	-	ILS	Annual
Gross Profit	`GrossProfit`	$466.00K	USD	Annual
Gross Profit	`GrossProfit`	292,000.00	ILS	Annual
Gross Profit	`GrossProfit`	-	ILS	Annual
Gross Profit	`GrossProfit`	1.62M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$4.88M	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	16.92M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	29.20M	ILS	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	22.92M	ILS	Annual
Participation in research and development expenses	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	-2.85M	ILS	Annual
Participation in research and development expenses	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	-12.41M	ILS	Annual
Participation in research and development expenses	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	-11.05M	ILS	Annual
Participation in research and development expenses	`TransfersOfResearchAndDevelopmentFromEntityRelatedPartyTransactions`	$-823.00K	USD	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	14.07M	ILS	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	$4.06M	USD	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	16.79M	ILS	Annual
Research and development expenses, net	`ResearchAndDevelopmentExpenseNet`	11.86M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	$2.39M	USD	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	6.95M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	11.05M	ILS	Annual
General, administrative and marketing expenses	`SellingGeneralAndAdministrativeExpense`	8.30M	ILS	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-27.55M	ILS	Annual
Operating loss	`ProfitLossFromOperatingActivities`	$-5.99M	USD	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-18.81M	ILS	Annual
Operating loss	`ProfitLossFromOperatingActivities`	-20.75M	ILS	Annual
Financial income	`FinanceIncome`	215,000.00	ILS	Annual
Financial income	`FinanceIncome`	253,000.00	ILS	Annual
Financial income	`FinanceIncome`	$74.00K	USD	Annual
Financial income	`FinanceIncome`	93,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	$110.00K	USD	Annual
Financial expenses	`FinanceCosts`	51,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	441,000.00	ILS	Annual
Financial expenses	`FinanceCosts`	380,000.00	ILS	Annual
Financial expenses (income), net	`FinanceIncomeCost`	164,000.00	ILS	Annual
Financial expenses (income), net	`FinanceIncomeCost`	$-36.00K	USD	Annual
Financial expenses (income), net	`FinanceIncomeCost`	-348,000.00	ILS	Annual
Financial expenses (income), net	`FinanceIncomeCost`	-127,000.00	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	$-6.02M	USD	Annual
Comprehensive loss	`ComprehensiveIncome`	-18.65M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-20.88M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-27.89M	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.28	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	$0.05	USD	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.22	ILS	Annual
Basic and diluted loss per ordinary share (NIS/USD)	`BasicAndDilutedEarningsLossPerShare`	0.16	ILS	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	100.62M	shares	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	133.19M	shares	Annual
Weighted average ordinary shares outstanding	`WeightedAverageShares`	84.67M	shares	Annual

Cash Flow Statement 116 line items

Line Item	Tag	Value	Unit	Period
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-19.36M	ILS	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	$-5.16M	USD	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-14.50M	ILS	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	-17.88M	ILS	Annual
Interest received	`InterestReceivedClassifiedAsOperatingActivities`	-	ILS	Annual
Interest received	`InterestReceivedClassifiedAsOperatingActivities`	1,000.00	ILS	Annual
Interest received	`InterestReceivedClassifiedAsOperatingActivities`	-	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-17.88M	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-14.50M	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	-19.36M	ILS	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-5.16M	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$129.00K	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	447,000.00	ILS	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	1.39M	ILS	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	492,000.00	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-129.00K	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-1.39M	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-492,000.00	ILS	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	-447,000.00	ILS	Annual
Proceeds from issue of shares, warrants and debentures, less issue expenses	`ProceedsFromIssuingShares`	29.03M	ILS	Annual
Proceeds from issue of shares, warrants and debentures, less issue expenses	`ProceedsFromIssuingShares`	18.50M	ILS	Annual
Proceeds from issue of shares, warrants and debentures, less issue expenses	`ProceedsFromIssuingShares`	$8.37M	USD	Annual
Proceeds from issue of shares, warrants and debentures, less issue expenses	`ProceedsFromIssuingShares`	10.01M	ILS	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	-	ILS	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	$1.04M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	27,000.00	ILS	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	3.62M	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	19,000.00	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$73.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	253,000.00	ILS	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	-	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	10.04M	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	32.40M	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	18.49M	ILS	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$9.35M	USD	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	-5.85M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	14.06M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	-1.36M	ILS	Annual
Increase (Decrease) in cash and cash equivalents	`IncreaseDecreaseInCashAndCashEquivalents`	$4.06M	USD	Annual
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	11.06M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	$1.09M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents at the beginning of the year	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	-104,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	157,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	44,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$13.00K	USD	Annual
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	$1.09M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	11.06M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	5.32M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	3.80M	ILS	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	$5.14M	USD	Point-in-time
Cash and cash equivalents at the end of the year	`CashAndCashEquivalents`	17.82M	ILS	Point-in-time
Comprehensive loss	`ComprehensiveIncome`	-27.89M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-20.88M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	-18.65M	ILS	Annual
Comprehensive loss	`ComprehensiveIncome`	$-6.02M	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	788,000.00	ILS	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$303.00K	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	864,000.00	ILS	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	1.05M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	3.57M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	4.97M	ILS	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$1.43M	USD	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	4.08M	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	-104,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	157,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	44,000.00	ILS	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$13.00K	USD	Annual
Interest received	`AdjustmentsForInterestIncome`	-1,000.00	ILS	Annual
Gain from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	$-10.00K	USD	Annual
Gain from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-	ILS	Annual
Gain from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-35,000.00	ILS	Annual
Gain from changes in fair value of financial instruments	`AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities`	-	ILS	Annual
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	8,000.00	ILS	Annual
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	54,000.00	ILS	Annual
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	-1,000.00	ILS	Annual
Exchange differences on restricted cash	`EffectOfExchangeRateChangesOnRestrictedCash`	$16.00K	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-4.27M	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-14.80M	ILS	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-23.29M	ILS	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	-13.89M	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-1.69M	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-544,000.00	ILS	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-40.00K	USD	Annual
Increase in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	-137,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-213,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	-487,000.00	ILS	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-61.00K	USD	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$29.00K	USD	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	-21,000.00	ILS	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	101,000.00	ILS	Annual
Decrease (increase) in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	-95,000.00	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	-2.24M	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	854,000.00	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	2.50M	ILS	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$-646.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	382,000.00	ILS	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$109.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	379,000.00	ILS	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	249,000.00	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	-978,000.00	ILS	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	$-282.00K	USD	Annual
Increase (decrease) in royalties to the IIA	`AdjustmentsForIncreaseDecreaseInOtherLiabilities`	2.18M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	-611,000.00	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	3.94M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	-3.09M	ILS	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$-891.00K	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	$-5.16M	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-19.36M	ILS	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-17.88M	ILS	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	-14.50M	ILS	Annual
Acquisition of fixed assets against issue of shares and credit See Note 13(A)(1)(C).	`AcquisitionOfFixedAssetsAgainstIssueOfShares`	1.68M	ILS	Annual

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Proceeds from issue of shares and options, less issue expenses	`ProceedsFromIssueOfSharesAndOptionsLessIssueExpenses`	1.30M	ILS	Annual
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssueOfSharesAndWarrantsNetOfIssueExpenses`	1.33M	ILS	Annual
Proceeds from issue of shares, warrants and debentures, net of issue expenses	`ProceedsFromIssueOfSharesWarrantsAndDebenturesNetOfIssueExpenses`	$182.00K	USD	Annual
Proceeds from issue of shares, warrants and debentures, net of issue expenses	`ProceedsFromIssueOfSharesWarrantsAndDebenturesNetOfIssueExpenses`	634,000.00	ILS	Annual
Balance	`Equity`	14.31M	ILS	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time
Balance	`Equity`	$1.49M	USD	Point-in-time
Balance	`Equity`	$2.62M	USD	Point-in-time
Balance	`Equity`	9.78M	ILS	Point-in-time
Balance	`Equity`	9.08M	ILS	Point-in-time
Comprehensive loss	`ProfitLoss`	-27.89M	ILS	Annual
Comprehensive loss	`ProfitLoss`	-18.65M	ILS	Annual
Comprehensive loss	`ProfitLoss`	-20.88M	ILS	Annual
Comprehensive loss	`ProfitLoss`	$-6.02M	USD	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$1.43M	USD	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	4.97M	ILS	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	4.08M	ILS	Annual
Share-based compensation to employees and consultants	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	3.57M	ILS	Annual
Proceeds from issue of shares and options, less issue expenses	`ProceedsFromIssueOfSharesAndOptions`	10.01M	ILS	Annual
Proceeds from issue of shares and options, less issue expenses	`ProceedsFromIssueOfSharesAndOptions`	$1.04M	USD	Annual
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssueOfSharesAndWarrants`	$4.68M	USD	Annual
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssueOfSharesAndWarrants`	16.21M	ILS	Annual
Proceeds from issue of shares and warrants, net of issue expenses	`ProceedsFromIssueOfSharesAndWarrants`	18.50M	ILS	Annual
Exercise of options into shares	`IncreaseDecreaseThroughExerciseOfOptions`	27,000.00	ILS	Annual
Exercise of warrants into shares	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	$1.04M	USD	Annual
Exercise of warrants into shares	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	3.62M	ILS	Annual
Issue of shares	`ShareIssueRelatedCost`	684,000.00	ILS	Point-in-time
Issue of shares	`ShareIssueRelatedCost`	643,000.00	ILS	Point-in-time
Issue of shares	`ShareIssueRelatedCost`	1.30M	ILS	Point-in-time
Issue of shares	`ShareIssueRelatedCost`	404,000.00	ILS	Point-in-time
Issue of shares	`ShareIssueRelatedCost`	1.20M	ILS	Annual
Balance	`Equity`	9.78M	ILS	Point-in-time
Balance	`Equity`	$2.62M	USD	Point-in-time
Balance	`Equity`	9.08M	ILS	Point-in-time
Balance	`Equity`	5.16M	ILS	Point-in-time
Balance	`Equity`	14.31M	ILS	Point-in-time
Balance	`Equity`	$1.49M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.